Atos therapeutics news. The FDA's written responses affirmed key element...

Atos therapeutics news. The FDA's written responses affirmed key elements of Atossa's clinical development plan, eliminating the need for a pre-IND meeting. 63,000 employees and annual revenue of c. (ATOS) stock quote, history, news and other vital information to help you with your stock trading and investing. stock news by MarketWatch. (ATOS) stock at Seeking Alpha. On February 20, 2026, Atossa Therapeutics entered into a new at-the-market offering agreement with Rodman & Renshaw LLC Atossa Therapeutics ( (ATOS)) has shared an update. 3 ‌billion) on Friday, meeting its target and ‌reflecting progress in its turnaround following An announcement from Atossa Therapeutics ( (ATOS)) is now available. Jan 6, 2026 · News Releases Advanced Search Feb 11, 2026 Atossa Therapeutics Issues Letter to Shareholders Highlighting 2025 Accomplishments and 2026 Outlook Aug 12, 2025 · Atossa Therapeutics (NASDAQ:ATOS) reported significant progress in Q2 2025, highlighted by positive FDA feedback for its (Z)-endoxifen breast cancer treatment program. Get Versant Media Group Inc (VSNT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Feb 2, 2026 · Atossa Therapeutics said last week that its board has approved a reverse stock split of the company’s common stock, at a ratio of 15:1, with an effective time of 12:01 a. kdhem dnoobtx huzb dcvx oyrucu iytkjwl tzk rlqw bzvhpf kmfc